5.5% of patients discharged from EDs after nonfatal opioid overdose die within one year, yet only 5.8% of EDs have formal buprenorphine initiation protocols

Among 11,557 patients discharged from emergency departments after treatment for nonfatal opioid overdose, 5.5% (635 patients) died within one year and 1.1% (130 patients) died within one month, with the first two days representing the highest-risk period. Despite this, only 5.8% of emergency departments had formal protocols for initiating buprenorphine treatment in 2024, and even where capability existed, only 53.8% of eligible patients actually received ED-initiated buprenorphine. Why it matters: the emergency department is often the only point of contact between a person with opioid use disorder and the healthcare system, so failing to initiate medication during an overdose visit means losing the most critical intervention window, so patients are discharged back to the same environment and drug supply that caused the overdose without pharmacological protection, so 1 in 18 will die within a year and the highest mortality concentrates in the first 48 hours post-discharge, so the emergency medicine system treats the acute overdose as an isolated poisoning event rather than a chronic disease requiring immediate medication initiation. The structural root cause is that emergency medicine culture has historically defined its role as stabilization and discharge rather than chronic disease management, most ED physicians did not train to prescribe buprenorphine, hospital systems lack the follow-up referral networks to connect overdose survivors with ongoing addiction care after discharge, and the administrative burden of initiating a controlled substance prescription in a high-volume ED environment discourages adoption even among willing physicians.